January 6, 2026 Morning Full Broadcast: Refining, Defense, Drones, and Crypto Strong; Xi Jinping Emphasizes Anti-Japanese History, 14 Korea-China MOUs Including K-Food Exports, Samsung and SK Raise Server DRAM Prices by 70%

[26.01.06 오전 방송 전체보기] 정유, 방산, 드론, 코인까지 강세/ 시진핑, 한중 항일 역사 강조 K푸드 수출 등 14건 MOU, 삼성·SK, 서버용 D램값 70% 인상
Watch on YouTube ↗  |  January 06, 2026 at 03:33  |  6:14:56  |  3PRO TV (삼프로TV)
Speakers
Park Myung-seok — Curator
Kim Kyung-hwan — Team Leader
Kwon Soon-woo — Reporting Team Lead, 3PRO TV
Park Byeong-chang — Director, MP Partners
Vincent — Manager, Hana Securities
Park Geun-young — Managing Director, IBK Investment & Securities
Kim Jang-yeol — Reporter, The Bell
Noh Young-rae — Manager
Kim Se-han — Team Lead, Centerfield W
Lee Ji-eun — Representative of EasyStock

Summary

The morning broadcast reviewed a broad U.S. rally, Venezuela-driven moves in oil, defense, drones, gold and crypto, and the AI-driven server DRAM shortage that lifted Samsung and SK hynix. A China strategist discussed Hong Kong IPOs, advanced manufacturing exporters, HBM competition, and commercial space. Korean market segments focused on the sharp KOSPI rebound, semiconductor leadership, rotation into autos, robots, shipbuilding, nuclear, financials, biotech and select consumer names.

  • U.S. equities rose, with small caps, financials, energy, defense and drone stocks outperforming.
  • Gold, silver, copper and Bitcoin rallied while oil lagged on potential long-term Venezuelan supply.
  • Samsung and SK hynix raised server DRAM prices sharply amid an AI-driven memory shortage.
  • China is accelerating tech IPOs in Hong Kong and mainland markets, focusing on GPU, HBM and commercial space.
  • Korean stocks surged, led by semiconductors and then rotating into autos, robots, shipbuilding, nuclear and financials.
  • CES showcased humanoid robots, autonomous driving and AI devices, supporting robotics-related sentiment.
  • Crypto catalysts included the Clarity Act, Ethereum staking and Korea's stablecoin framework.
  • Analysts favored semiconductor equipment, biotech, defense, shipbuilding and select China-linked exporters.
Ideas
Palantir rebounds on defense-software usage
Palantir software was reportedly used in the Venezuela operation, and the stock rebounded about 4%, supporting its defense-software narrative.
Oral obesity launch favors Novo Nordisk
Novo Nordisk launched an oral obesity treatment in the U.S.; with insurance it can be cheap and has first-mover advantage versus Eli Lilly's oral candidate.
Nuclear and SMR names stay bullish
Centrus Energy support and SMR news lifted nuclear-related stocks including Doosan Enerbility, Centrus, Oklo and NuScale; nuclear names should remain on watch.
Geopolitical anxiety and weak dollar lift gold
Gold rose 2.9% above $4,450 despite Venezuela risk easing, with lingering geopolitical anxiety and dollar weakness supporting precious metals.
Silver rallies with precious metals complex
Silver rose 7% as the precious-metals rally continued alongside gold.
Venezuela supply may pressure oil lower
Oil barely rallied on Venezuela, and long-term development of Venezuela's large reserves could pressure crude prices lower.
Copper hits records; watch related stocks
Copper repeatedly hit record highs and copper-related stocks should be watched.
Chevron and Schlumberger gain from Venezuela rebuild
US policy aims to reopen Venezuela's oil sector; Chevron is the only remaining oil-infrastructure operator there, while oil-service names like Schlumberger may have greater upside.
Drone stocks surge on defense demand
Venezuela operations and defense demand lifted drone stocks; Ondas Holdings and Red Cat surged double digits.
Space stocks rally on Starlink catalyst
Space-related shares rallied; AST SpaceMobile jumped on Starlink service for Venezuela, while Planet Labs also stayed strong.
Bitcoin benefits from inflows and weak dollar
Bitcoin pushed toward $95,000 on renewed ETF inflows, BofA 1-4% allocation guidance, dollar weakness and geopolitical hedge demand.
Circle approval strengthens USDC infrastructure
Circle received conditional trust-bank approval, strengthening the USDC stablecoin infrastructure and its ability to monetize reserves.
Coinbase gains from USDC ecosystem growth
Coinbase rose with Circle's trust-bank approval and USDC linkage; Goldman Sachs is positive on its improving monetization structure.
DRAM shortage lifts Samsung and SK hynix
AI GPU/ASIC demand is driving a server DRAM shortage; Samsung and SK hynix lifted server DRAM quotes 60-70%, BofA raised SK hynix's target to 1,000,000 KRW, and memory tightness may last into 2027-28.
TSMC benefits from GPU and ASIC orders
Goldman Sachs positive coverage and record-high shares reflect TSMC's position as the sole foundry for GPU and ASIC leaders; pricing power depends on Nvidia versus Broadcom/Google orders.
ASIC growth matches GPUs by 2027
Goldman expects ASIC volumes to match GPU volumes by 2027 as Google TPU, Amazon Trainium and Broadcom-designed custom chips grow; memory demand remains tied to both.
AI racks lift power and Bloom Energy
Foxconn's AI rack growth and UBS's 800V data-center power call point to rising power/connectivity demand; UBS highlighted Bloom Energy as a provider of such power solutions.
Tesla pullback is buying opportunity
Tesla rebounded after seven down days; Cantor Fitzgerald viewed the pullback as a buying opportunity with FSD China/Europe, robotaxi, and Cybercab catalysts ahead.
Kim Kyung-hwan Team Leader 47:32
Hong Kong Exchange wins IPO boom
Hong Kong was the top global IPO venue and China is using a two-track listing strategy; HKEX benefits as foreign investors return and Chinese companies list in Hong Kong.
Kim Kyung-hwan Team Leader 67:43
Buy China's advanced manufacturing exporters
China's market-cap mix is shifting toward advanced manufacturing, exporters and AI tech; policy favors supply-chain and export champions, so top Chinese manufacturing/export companies can re-rate.
Kim Kyung-hwan Team Leader 76:16
BYD needs restructuring before new highs
BYD's exports are strong but domestic price wars and subsidy cuts require industry restructuring; the stock may not break upward meaningfully this year, though BYD and Xiaomi should survive.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 88:26
SK hynix preferred for HBM competitiveness
He personally prefers SK hynix over Samsung because of HBM competitiveness, even though Samsung may have more stock upside from unresolved optionality.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 89:50
Hyundai Motor wins on Atlas robots
Hyundai Motor plans to mass-produce 30,000 Atlas humanoid robots by 2028; physical-AI robotics exposure drove the stock and should support valuation.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 98:51
Shinsegae AliBaba deal may hurt retail
Shinsegae's AliBaba MOU may make Gmarket a route for Chinese goods into Korea, increasing Chinese e-commerce penetration and pressuring domestic retail; keep watching.
Park Byeong-chang Director, MP Partners 118:31
AI capex lifts semiconductor equipment names
AI data-center capex plus aged-equipment replacement drove ASML, Applied Materials and Lam Research sharply higher; semiconductor equipment should benefit.
Park Byeong-chang Director, MP Partners 126:52
KOSPI not expensive; upside remains
KOSPI's forward P/E around 10.2x is not expensive; EPS upgrades from Samsung/SK hynix can support 4,600-5,000, though a short-term pullback is possible.
Park Byeong-chang Director, MP Partners 142:04
SMR and power semis get tax support
Korea is considering designating SMR and power semiconductors as national strategic technologies with tax support, adding policy momentum to nuclear/power semis.
Park Byeong-chang Director, MP Partners 144:19
Solid-state battery commercialization hopes rise
Hyundai produced vehicle-installable solid-state battery prototypes at its pilot line; solid-state battery developers rallied on commercialization hopes.
Park Byeong-chang Director, MP Partners 147:47
Korean defense earnings rebound continues
Hanwha Aerospace, Hyundai Rotem, LIG Nex1 and Korea Aerospace are expected to grow 2026 operating profit about 20% to KRW 6.6tn after already doubling; defense was oversold and is rebounding.
Vincent Manager, Hana Securities 154:37
Buy Korean semiconductor leaders on dips
Foreign inflows into a weak-won Korea should target market-cap leaders; AI memory expectations and sold-out HBM support Samsung/SK hynix; buy leading stocks on dips.
Vincent Manager, Hana Securities 175:29
Weak won benefits Korean exporters
The won's real effective exchange rate is likely to stay weak like China's, which benefits Korean export companies.
Vincent Manager, Hana Securities 176:57
Avoid Hallyu; favor exporters instead
China reopening/Hallyu beneficiaries like entertainment, cosmetics, leisure and duty-free are overpriced and uncertain; weak-won effects favor exporters/semiconductors instead.
Kim Jang-yeol Reporter, The Bell 188:48
PharmaResearch exports drive record earnings
December filler exports jumped sharply, mostly from PharmaResearch; Q4 operating profit may hit a record and the stock looks oversold.
Park Geun-young Managing Director, IBK Investment & Securities 193:26
Power equipment looks expensive versus semis
Power-equipment names such as HD Hyundai Electric, Hyosung Heavy and LS Electric trade near 26x forward P/E and lack the relative momentum of semiconductors/equipment.
Kim Jang-yeol Reporter, The Bell 228:47
Korean financials gain from market boom
US financials are being re-rated as AI efficiency beneficiaries; Korean securities and banks should benefit from high KOSPI turnover, and Mirae Asset Securities has SpaceX investment gains.
Kim Jang-yeol Reporter, The Bell 231:54
Tiered allocation favors nuclear and defense
For balanced exposure, prioritize nuclear/defense/power equipment as first tier and bio/auto/robots as second tier, while keeping a semiconductor core and cash buffer.
Kim Jang-yeol Reporter, The Bell 231:54
Tiered allocation favors nuclear and defense
For balanced exposure, prioritize nuclear/defense/power equipment as first tier and bio/auto/robots as second tier, while keeping a semiconductor core and cash buffer.
US big tech AI cycle continues
The US cannot stop the AI/tech cycle while competing with China, and stock-option wealth creation requires high valuations; keep parking funds in US big tech and AI value-chain names.
Korean semiconductor equipment benefits from relocation
Taiwan supply-chain risk and Apple's China exit could force fab relocation and new semiconductor equipment installations; he plans to trade Korean semiconductor equipment heavily this year.
Korean biotech license-out cycle builds
After decades of investment, Korean biotech began producing major license-out deals in 2025; more are expected in 2026, supporting the sector.
Tomocube offers organoid analysis optionality
Tomocube's holographic microscope analyzes organoids without cutting or staining, is being adopted by global pharma, and has optionality in glass-substrate inspection though not yet mass produced.
Onconic has GERD cash and cancer pipeline
Onconic's Jaqbo GERD drug has fast onset, self-developed export rights, and rapid sales growth; cash funds a dual synthetic-lethality cancer pipeline with May data and licensing potential.
Hacto has stablecoin wallet optionality
Hacto Innovation uses cash from its security business to fund premium probiotics and digital wallet; it is Korea's only selected Circle Arc digital wallet partner, offering stablecoin payment optionality.
Kim Se-han Team Lead, Centerfield W 302:14
Crypto breaks highs if policy passes
If liquidity continues and 1Q policy catalysts such as the Clarity Act and Ethereum staking pass, Bitcoin and Ethereum should break prior highs; otherwise the wait may extend 2-3 years.
Kim Se-han Team Lead, Centerfield W 304:30
Korean stablecoin law lifts related stocks
Korea's digital asset basic law allowing bank-led stablecoin consortia and tech-company shareholders should revive Korean stablecoin and digital-asset-related stocks.
Kim Se-han Team Lead, Centerfield W 309:38
Strategy faces MSCI and mNAV risk
Strategy's convertible/preferred model can survive an 80% Bitcoin drop given 6.6x collateral, but MSCI deletion risk in January and a near-1 mNAV make the stock less attractive; watch Jan 16.
Kim Se-han Team Lead, Centerfield W 334:30
US financials win from deregulation and AI
Trump deregulation and AI-driven efficiency are re-rating US financials, while stablecoin/tokenization infrastructure offers new fee streams.
Kim Se-han Team Lead, Centerfield W 342:03
Bitmine becomes Ethereum institutional platform
Bitmine controls about 3% of Ethereum and is building institutional Ethereum staking infrastructure; it can earn from holdings, infrastructure and staking, and may surpass Strategy.
Lee Ji-eun Representative of EasyStock 355:00
AI power demand favors nuclear names
AI power demand and US nuclear/SMR permitting progress, plus Korea's SMR strategic-tech push, make the power/nuclear selloff an opportunity.
Lee Ji-eun Representative of EasyStock 356:50
Mirae Asset gains from SpaceX stake
Mirae Asset Securities rose on reports that its SpaceX investment gains will sharply boost earnings; SpaceX-related financial holdings gained.
Lee Ji-eun Representative of EasyStock 358:45
Korean shipbuilders gain on order shift
Container-ship orders are shifting to Korea amid China exclusion and LNG carrier orders expand; 2026 earnings should level up even if valuation rerating is slower.
Lee Ji-eun Representative of EasyStock 360:42
Naver gains users from Coupang breach
Coupang's data breach led to user attrition while Naver's MAU rose about 10%, creating a reverse-benefit e-commerce expectation.
Lee Ji-eun Representative of EasyStock 362:44
HYBE leads on artist comeback catalysts
Korea-China cultural exchange news helps entertainment, but the better thesis is BTS/Blackpink/EXO/Big Bang activity; HYBE is the top pick with chart support at the 5-day line.
Lee Ji-eun Representative of EasyStock 367:00
Cosmetics may lag semiconductor leadership
K-beauty is still growing in the US, but AI/semiconductor leadership makes investors reluctant to rotate into cosmetics; the sector may need more time.
Lee Ji-eun Representative of EasyStock 368:07
Korean bio supported by deal catalysts
JP Morgan Healthcare and potential big-pharma deals support Korean biotech; Samsung Biologics is in big-deal talks and the sector looks positive.
Up Next

This 3PRO TV (삼프로TV) video, published January 06, 2026, features Park Myung-seok, Kim Kyung-hwan, Kwon Soon-woo, Park Byeong-chang, Vincent, Kim Jang-yeol, Park Geun-young, Noh Young-rae, Kim Se-han, Lee Ji-eun discussing PLTR, NVO, 034020.KS, LEU, OKLO, SMR, GLD, SILVER, WTI, COPPER, CVX, SLB, ONDS, RCAT, ASTS, PL, BTC, CRCL, COIN, 005930.KS, 000660.KS, MU, TSM, AVGO, BE, TSLA, 0388.HK, FXI, 1211.HK, 005380.KS, 004170.KS, ASML, AMAT, LRCX, EWY, Solid-state battery, 012450.KS, 064350.KS, 079550.KS, 047810.KS, Korean entertainment, Korean cosmetics, Korean leisure/duty-free, 214450.KQ, 267260.KS, 298040.KS, 010120.KS, 006800.KS, 039490.KS, 323410.KS, 005940.KS, Korean nuclear, Korean Defense, Power equipment, Korean bio, Korean autos, Korean robots, US Big Tech, AIQ, Korean semiconductor equipment, Korean biotech/healthcare, Tomocube, Onconic Therapeutics, 214180.KQ, ETH, Korean stablecoin/digital asset stocks, MSTR, XLF, BMNR, 329180.KS, 042660.KS, 010140.KS, 035420.KS, 352820.KS, XBI, 207940.KS. 55 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Park Myung-seok, Kim Kyung-hwan, Kwon Soon-woo, Park Byeong-chang, Vincent, Kim Jang-yeol, Park Geun-young, Noh Young-rae, Kim Se-han, Lee Ji-eun  · Tickers: PLTR, NVO, 034020.KS, LEU, OKLO, SMR, GLD, SILVER, WTI, COPPER, CVX, SLB, ONDS, RCAT, ASTS, PL, BTC, CRCL, COIN, 005930.KS, 000660.KS, MU, TSM, AVGO, BE, TSLA, 0388.HK, FXI, 1211.HK, 005380.KS, 004170.KS, ASML, AMAT, LRCX, EWY, Solid-state battery, 012450.KS, 064350.KS, 079550.KS, 047810.KS, Korean entertainment, Korean cosmetics, Korean leisure/duty-free, 214450.KQ, 267260.KS, 298040.KS, 010120.KS, 006800.KS, 039490.KS, 323410.KS, 005940.KS, Korean nuclear, Korean Defense, Power equipment, Korean bio, Korean autos, Korean robots, US Big Tech, AIQ, Korean semiconductor equipment, Korean biotech/healthcare, Tomocube, Onconic Therapeutics, 214180.KQ, ETH, Korean stablecoin/digital asset stocks, MSTR, XLF, BMNR, 329180.KS, 042660.KS, 010140.KS, 035420.KS, 352820.KS, XBI, 207940.KS